IBA Dosimetry

What IBA Dosimetry does

IBA Dosimetry GmbH, headquartered in Schwarzenbruck, Germany, is a wholly-owned subsidiary of IBA (Ion Beam Applications S.A., EURONEXT: IBAB) and operates as the Dosimetry segment within IBA Clinical. With approximately 220 employees drawn from around 30 nationalities, the company designs and manufactures quality assurance hardware, software and services for radiation therapy, proton/particle therapy and medical imaging, serving more than 10,000 customers across 125+ countries.

The product portfolio centers on the myQA software platform, which integrates patient QA, machine QA, beam scanning and centralized QA data management across departments and satellite sites via a central SQL database. Hardware includes the Blue Phantom family of 3D and 2D water phantoms (Blue Phantom², Blue Phantom COMPACT, Blue Phantom Helix, myQA Blue Phantom³), detector systems such as MatriXX arrays, the Stealth Chamber and RAZOR diode and ionization chambers, plus phantoms for CT, mammography and motion management. The October 2025 acquisition of PhantomX GmbH added AI imaging QA phantoms, and a steady 2025-2026 launch cadence has introduced MR-guided RT, respiratory motion and particle therapy products. Services include DAkkS-accredited Secondary Standard Dosimetry Laboratory calibration, Monte Carlo-based Beam Data Verification Audit, and tiered software support contracts.

IBA Dosimetry monetizes through a mix of hardware sales (phantoms, detectors, instruments), recurring software subscriptions and licenses on the myQA platform, professional services (SSDL calibration, Monte Carlo beam audits) and customizable service and support contracts. Go-to-market is enterprise field sales via regional dosimetry consultants, complemented by conference presence at ESTRO, AAPM, RSNA, ECMP, DGMP and DEGRO, inside-sales website inquiry capture, and digital channels including LinkedIn, YouTube, webinars and a WeChina WeChat presence. Customer segments span radiation therapy centers, proton/particle therapy facilities, medical imaging departments and the medical physicist persona responsible for commissioning and ongoing QA.

Name

IBA Dosimetry

Legal name

IBA Dosimetry GmbH

Website

https://iba-dosimetry.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

251–500 employees

Short description

IBA Dosimetry GmbH is a Germany-based, wholly-owned subsidiary of IBA S.A. that designs and manufactures dosimetry and quality assurance hardware, software and services for radiation therapy, proton therapy and medical imaging, serving more than 10,000 customers across 125+ countries.

Ownership category

akta.pro rank

Product category

Medical Physics Quality Assurance Equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Irradiation Apparatus Manufacturing (334517), Diagnostic Imaging Centers (621512), Testing Laboratories and Services (541380)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)

akta.pro primary industry

Radiation Dose Management & Analytics (HLACALAH)

akta.pro secondary industries

Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs) (EUAKAIAH), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), X-ray & Fluoroscopy Systems (HLAHABAA)

Keywords

• Radiation dosimetry systems
• Medical physics QA
• Beam commissioning services
• Proton therapy QA
• Diagnostic imaging QA

Headquarters

HQ city

Schwarzenbruck

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Dosimetry Equipment Hardware Sales: Sale of dosimetry equipment including water phantoms, ionization chambers, diode detectors, and QA systems for radiation therapy and medical imaging.
2. Software Subscriptions and Licenses: myQA software platform with various modules for beam scanning, patient QA, machine QA, and integrated protocol-based QA. Includes software updates and compliance features.
3. Service and Support Contracts: Service contracts covering 24/7 support, online portal access, fast repair, loaner systems, and automatic software updates. myQA Coverage package for software maintenance.
4. Calibration Services: SSDL (Secondary Standard Dosimetry Laboratory) calibration services for dosimeters, detectors, electrometers used in radiation therapy and medical imaging, with internationally recognized certifications.
5. Beam Data Verification Audit: Independent audit service using Monte Carlo-based verification to validate beam data accuracy for commissioning and annual QA.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

IBA Dosimetry designs, manufactures, and services quality assurance hardware and software for radiation therapy, particle therapy, and diagnostic medical imaging. Its portfolio centers on water phantoms, 2D ionization arrays, ionization chambers and diode detectors for beam commissioning and patient-specific QA, anthropomorphic phantoms for diagnostic imaging, and the myQA software platform that unifies machine, patient, and SRS QA workflows. Recurring services include preventive maintenance, on-site and DAkkS-accredited calibration, beam data verification audits, and SSDL calibration services for national metrology institutes.

Product overview

IBA Dosimetry provides a comprehensive portfolio of Quality Assurance solutions for radiation therapy, proton therapy, and medical imaging. The product ecosystem centers on the myQA software platform (myQA Platform) which integrates patient QA, machine QA, beam scanning, and data management. Hardware products include water phantoms (Blue Phantom², Blue Phantom COMPACT, Blue Phantom Helix, myQA Blue Phantom³) for beam scanning and commissioning, detector arrays (MatriXX, Stealth Chamber, RAZOR series) for dosimetry, and medical imaging phantoms (PhantomX series, CT-IQ, Accu-Gold, KermaX-plus). The portfolio was significantly expanded in 2025-2026 with AI-integrated QA solutions through PhantomX acquisition, new products including QUASAR GRID3D Advantage for MR-guided RT, myQA Blue Phantom³ with automatic levelling, myQA MatriXX AiR for particle therapy, and myQA StarTrack³. Services include SSDL calibration, Beam Data Verification Audit with Monte Carlo, and comprehensive support contracts. Products are designed for compatibility with major treatment systems including Varian, Elekta, CyberKnife, TomoTherapy, and proton therapy platforms, with DICOM integration across the software suite.

Differentiator

Problem solved

Functional benefit

Brands

• myQA Platform: Centralized quality assurance software platform integrating patient and machine QA data
• myQA Accept
• myQA Machines
• myQA Patients
• myQA SRS
• Blue Phantom
• Stealth Chamber
• RAZOR Detector
• QUASAR
• MatriXX
• ICC International Competence Center

Products and services

• Blue Phantom²
• Blue Phantom COMPACT
• Blue Phantom Helix
• MatriXX Resolution
• MatriXX PT/ONE
• RAZOR Diode Detector
• RAZOR Chamber
• RAZOR Nano Chamber
• Stealth Chamber
• PhantomX Head/Neck and Pure Breast Phantoms
• CT-IQ Phantom
• Accu-Gold T3
• LXcan
• KermaX-plus
• QUASAR pRESP 2.0 and GRID3D Advantage
• myQA Platform
• myQA Machines
• myQA Patients
• myQA SRS
• myQA Cockpit
• myQA Accept
• Beam Data Verification Audit
• SSDL Calibration Services
• myQA Coverage
• Preventive Maintenance Inspection

Quantifiable outcome

• Saves 2 hours each commissioning day by avoiding frequent repositioning and room reentries with Stealth Chamber
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

AI capability3 records

Feature6 records

Partnerships

One partnership is on record.

• PhantomX GmbHcoreStrategic or Co-development PartnerIBA integrated Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH (announced October 2025). PhantomX supplies a new generation of highly realistic phantoms for clinical imaging and AI in medical imaging, strengthening IBA's Medical Imaging QA portfolio.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/ibadosimetry
• LinkedInlinkedin.com/company/iba-dosimetry-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IBA Dosimetry